Resmed (RMD) Shares Repurchased (2009 - 2026)

Resmed has reported Shares Repurchased for 12 years, with the latest figure at $175.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased rose 133.27% year-over-year to $175.0 million; the trailing twelve-month figure through Mar 2026 stood at $600.0 million (up 140.0% YoY), and the FY2025 full-year result was $300.0 million, up 100.0% from the prior year.
• Shares Repurchased for Q1 2026 stood at $175.0 million, roughly flat from $175.0 million in the prior quarter.
• The five-year high for Shares Repurchased was $175.0 million in Q4 2025, with the low at $50.0 million in Q1 2024.
• Historically, Shares Repurchased has averaged $95.0 million across 4 years, with a median of $75.0 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Repurchased soared 49.95% — and 2025, when it jumped 199.99%.
• Resmed's Shares Repurchased stood at $50.0 million in 2023, then soared by 49.95% to $75.0 million in 2024, then soared by 133.4% to $175.0 million in 2025, then retreated by 0.0% to $175.0 million in 2026.
• The last three Shares Repurchased figures came in at $175.0 million (Q1 2026), $175.0 million (Q4 2025), and $150.0 million (Q3 2025), per Business Quant data.